SShortSingh.
Back to feed

Heart transplant recipient battles insurer to retain life-saving anti-rejection drug

0
·1 views

Payton Herres received a heart transplant at age 11 due to a congenital condition called Ebstein's anomaly. Fifteen years after her surgery, she found herself unable to access everolimus, the anti-rejection medication she had depended on since 2013. Her insurer stopped covering the drug, and its out-of-pocket cost became unaffordable. Herres shared her situation on social media, where her story gained widespread attention. Entrepreneur Mark Cuban's pharmacy company stepped in to supply the medication at a significantly reduced price.

Read the full story at Times of India

This is an AI-generated summary. ShortSingh links to the original source for the complete article.

Discussion (0)

Log in to join the discussion and vote.

Log in

Related stories

0
IndiaTimes of India ·

Kerala consumer panel orders matrimonial site to refund Rs 15K for unmet match promise

A Kerala consumer commission has ruled against a matrimonial website for deficiency in service after it failed to deliver on its promises. The site had guaranteed 100 matches to a subscriber but provided only 51 contacts during the subscription period. While the commission acknowledged that 51 contacts were delivered, it still upheld the finding of service deficiency. The refund amount was revised downward from what the district commission had originally ordered, settling at Rs 15,000. The matrimonial company's appeal was dismissed, and the deficiency ruling was confirmed.